One-month TB prevention regimen just as effective as 9-month regimen

Published Date:

03/06/2018

Publication:

NAM AIDSMap

. . . Speaking at a press conference after the presentation, Professor Chaisson said “This 1HP regimen could dramatically alter the landscape for the prevention of TB in people with HIV. The likelihood of completing it is extremely high and the likelihood of it preventing TB is extremely high.”

“We think it is a large enough, clear enough result, that it can form the basis of new guidelines.” . . . 

Access Full Article

Clinical Trials

A5225: Phase I/II Dose-Finding Study of High-Dose...

A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...

Read More

A5302:  BioBank for Surrogate Marker Research for TB...

Primary Objective To obtain sputum, serum, urine, and peripheral blood mononuclear cells (PBMCs) for central TB biorepository...

Read More

A5207, Maintaining Options for Mothers Study (MOMS): A Phase...

A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...

Read More

A5282: A Randomized, Phase II Trial to Compare an HPV...

The investigators are looking for a better way to prevent cervical cancer. This study is comparing two different methods to...

Read More

P1077BF: Breastfeeding Version of the PROMISE Study...

1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...

Read More